Literature DB >> 3840080

1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture.

L K Cantley, J Russell, D Lettieri, L M Sherwood.   

Abstract

To determine whether 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] regulates PTH secretion, we have tested its effects in both short term incubations (30-120 min) and long term primary cell cultures (24-96 h) of bovine parathyroid cells. In short term incubations, 10(-11)-10(-7) M 1,25-(OH)2D3 had no consistent effect on PTH secretion. In primary cultures of bovine parathyroid cells, significant suppression of PTH secretion occurred, as measured by both N-terminal and C-terminal PTH assays. Suppression of PTH secretion was dose dependent when 10(-11), 10(-9), and 10(-7) M 1,25-(OH)2D3 were tested for 48 h in culture, and the effects of 10(-7) M, 1,25-(OH)2D3 were noted as early as 24 h. Reversal of suppression of PTH secretion was observed after an additional 48 h in the absence of 1,25-(OH)2D3. Other studies from our laboratory have demonstrated that 1,25-(OH)2D3 suppresses levels of pre-pro-PTH mRNA in cultured bovine parathyroid cells, and we found a strong correlation at 48 h between the decrease in PTH release and that in mRNA. We conclude that 1) 1,25-(OH)2D3 suppresses PTH secretion rates in a dose-dependent manner in cells grown for 24-48 h in culture, but does not have a significant effect on short term PTH release (30-120 min); 2) cultured cells exhibiting suppression by 1,25-(OH)2D3 demonstrate nearly full recovery of PTH secretion after an additional 48 h in the absence of added 1,25-(OH)2D3; and 3) PTH secretion closely parallels levels of pre-pro-PTH mRNA in cultured cells, suggesting that the observed effects of PTH secretion reflect, at least in part, suppression of synthesis of PTH by 1,25-(OH)2D3.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840080     DOI: 10.1210/endo-117-5-2114

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  29 in total

Review 1.  Cellular physiology and pathophysiology of the parathyroid glands.

Authors:  G Akerström; J Rastad; S Ljunghall; P Ridefelt; C Juhlin; E Gylfe
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 2.  Vitamin D and analogues in renal bone disease and implications for osteoporosis.

Authors:  J A Kanis; E V McCloskey; M N Beneton
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Regulation of protein kinase C by extracellular calcium in bovine parathyroid cells.

Authors:  N Kobayashi; J Russell; D Lettieri; L M Sherwood
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

4.  Effects of vitamin D3, 25-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion.

Authors:  L K Cantley; J B Russell; D S Lettieri; L M Sherwood
Journal:  Calcif Tissue Int       Date:  1987-07       Impact factor: 4.333

Review 5.  The regulation of parathyroid hormone secretion and synthesis.

Authors:  Rajiv Kumar; James R Thompson
Journal:  J Am Soc Nephrol       Date:  2010-12-16       Impact factor: 10.121

6.  Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.

Authors:  J A Delmez; C Tindira; P Grooms; A Dusso; D W Windus; E Slatopolsky
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

7.  Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure.

Authors:  S Lopez-Hilker; T Galceran; Y L Chan; N Rapp; K J Martin; E Slatopolsky
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

8.  Intramuscular calcitriol for uraemic children with severe hyperparathyroidism and hypercalcaemia.

Authors:  A Claris-Appiani; G L Ardissino; M C Tischer; A Bettinelli; A S Tirelli; V Daccò; G Castiglioni; F Pecchio; M Cunazza; B M Assael
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

9.  Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

Authors:  N Fukuda; H Tanaka; Y Tominaga; M Fukagawa; K Kurokawa; Y Seino
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 10.  Pleiotropic Activities of Vitamin D Receptors - Adequate Activation for Multiple Health Outcomes.

Authors:  Jackson W Ryan; Paul H Anderson; Howard A Morris
Journal:  Clin Biochem Rev       Date:  2015-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.